O	0	4	Cost
O	4	5	-
O	5	18	effectiveness
O	19	21	of
O	22	23	a
B-intervention	24	33	pragmatic
I-intervention	34	42	exercise
I-intervention	43	55	intervention
O	56	59	for
O	60	65	women
O	66	70	with
O	71	77	breast
O	78	84	cancer
O	84	85	:
O	86	93	results
O	94	98	from
O	99	100	a
O	101	111	randomized
O	112	122	controlled
O	123	128	trial
O	128	129	.

O	130	132	To
O	133	139	report
O	140	142	on
O	143	146	the
O	147	151	cost
O	151	152	-
O	152	165	effectiveness
O	166	168	of
O	169	172	the
O	173	181	Exercise
O	182	185	for
O	186	192	Health
O	193	198	trial
O	198	199	,
O	200	209	comparing
O	210	212	an
O	213	221	exercise
O	222	234	intervention
O	235	239	with
O	240	245	usual
O	246	250	care
O	251	257	during
O	258	261	and
O	262	271	following
O	272	281	treatment
O	282	285	for
O	286	291	women
O	292	296	with
O	297	303	breast
O	304	310	cancer
O	310	311	.

B-eligibility	312	317	Women
I-eligibility	318	322	with
I-eligibility	323	329	breast
I-eligibility	330	336	cancer
O	337	341	were
O	342	352	randomized
O	353	355	to
O	356	358	an
O	359	360	8
O	360	361	-
O	361	366	month
O	367	375	exercise
O	376	388	intervention
O	389	390	(
O	390	399	involving
O	400	407	regular
O	408	415	contact
O	416	420	with
O	421	423	an
O	424	432	exercise
O	433	445	physiologist
O	446	450	over
O	451	454	the
O	455	460	phone
O	460	461	,
O	462	463	n
O	464	465	=
B-intervention-participants	466	468	67
O	468	469	,
O	470	472	or
O	473	477	home
O	478	487	delivered
O	488	492	face
O	493	495	to
O	496	500	face
O	500	501	,
O	502	503	n
O	504	505	=
B-intervention-participants	506	508	67
O	508	509	)
O	510	512	or
B-control	513	518	usual
I-control	519	523	care
O	524	525	(
O	525	526	n
O	527	528	=
B-control-participants	529	531	60
O	531	532	)
O	533	538	group
O	539	542	and
O	543	547	were
O	548	556	assessed
O	557	560	pre
O	560	561	-
O	561	573	intervention
O	574	575	(
O	575	576	5
O	577	582	weeks
O	583	587	post
O	587	588	-
O	588	595	surgery
O	595	596	)
O	596	597	,
O	598	601	mid
O	601	602	-
O	602	614	intervention
O	615	616	(
O	616	617	6
O	618	624	months
O	625	629	post
O	629	630	-
O	630	637	surgery
O	637	638	)
O	638	639	,
O	640	643	and
O	644	646	10
O	647	652	weeks
O	653	657	post
O	657	658	-
O	658	670	intervention
O	671	672	(
O	672	674	12
O	675	681	months
O	682	686	post
O	686	687	-
O	687	694	surgery
O	694	695	)
O	695	696	.

O	697	700	The
O	701	708	benefit
O	709	717	measures
O	718	722	were
B-outcome-Measure	723	724	"
I-outcome-Measure	724	730	number
I-outcome-Measure	731	733	of
I-outcome-Measure	734	743	improvers
I-outcome-Measure	743	744	"
I-outcome-Measure	745	747	in
I-outcome-Measure	748	755	quality
I-outcome-Measure	756	758	of
I-outcome-Measure	759	763	life
O	764	765	(
O	765	769	FACT
O	769	770	-
O	770	771	B
O	771	772	+
O	772	773	4
O	773	774	)
O	775	778	and
B-outcome-Measure	779	786	quality
I-outcome-Measure	786	787	-
I-outcome-Measure	787	795	adjusted
I-outcome-Measure	796	800	life
I-outcome-Measure	801	806	years
I-outcome-Measure	807	808	(
I-outcome-Measure	808	813	QALYs
I-outcome-Measure	813	814	)
O	814	815	.

O	816	820	Data
O	821	823	on
O	824	832	provider
O	832	833	,
O	834	841	patient
O	841	842	,
O	843	846	and
O	847	857	government
O	858	863	costs
O	864	868	were
O	869	873	used
O	874	876	to
O	877	885	consider
O	886	887	2
O	888	892	cost
O	893	902	scenarios
O	902	903	:
O	904	905	(
O	905	906	1
O	906	907	)
O	908	909	a
O	910	917	service
O	918	926	provider
O	927	932	model
O	933	936	and
O	937	938	(
O	938	939	2
O	939	940	)
O	941	942	a
O	943	950	private
O	951	956	model
O	956	957	.

O	958	963	There
O	964	968	were
B-iv-bin-abs	969	971	69
B-outcome	972	981	improvers
O	982	984	in
O	985	988	the
O	989	1001	intervention
O	1002	1007	group
O	1008	1016	compared
O	1017	1021	with
B-cv-bin-abs	1022	1024	21
O	1025	1027	in
O	1028	1031	the
O	1032	1037	usual
O	1038	1042	care
O	1043	1048	group
O	1049	1050	(
O	1050	1054	odds
O	1055	1060	ratio
O	1061	1062	2
O	1062	1063	.
O	1063	1065	09
O	1065	1066	,
O	1067	1069	95
O	1069	1070	%
O	1071	1081	confidence
O	1082	1090	interval
O	1091	1092	1
O	1092	1093	.
O	1093	1095	08
O	1095	1096	,
O	1097	1098	4
O	1098	1099	.
O	1099	1101	01
O	1101	1102	;
O	1103	1104	P
O	1105	1106	=
O	1107	1108	.
O	1108	1111	033
O	1111	1112	)
O	1112	1113	.

O	1114	1117	The
B-outcome	1118	1129	incremental
I-outcome	1130	1134	cost
I-outcome	1135	1138	per
I-outcome	1139	1147	improver
O	1148	1151	was
O	1152	1153	A
O	1153	1154	$
O	1154	1158	2282
O	1159	1161	to
O	1162	1163	A
O	1163	1164	$
O	1164	1168	2644
O	1168	1169	.

B-outcome	1170	1177	Quality
I-outcome	1177	1178	-
I-outcome	1178	1186	adjusted
I-outcome	1187	1191	life
I-outcome	1192	1197	years
I-outcome	1198	1202	gain
O	1203	1206	for
O	1207	1210	the
O	1211	1223	intervention
O	1224	1229	group
O	1230	1236	versus
O	1237	1240	the
O	1241	1246	usual
O	1247	1251	care
O	1252	1257	group
O	1258	1261	was
O	1262	1263	0
O	1263	1264	.
O	1264	1267	009
O	1267	1268	,
O	1269	1273	with
O	1274	1285	incremental
O	1286	1290	cost
O	1291	1294	per
O	1295	1299	QALY
O	1300	1304	gain
O	1305	1308	for
O	1309	1315	models
O	1316	1317	1
O	1318	1321	and
O	1322	1323	2
O	1324	1329	being
O	1330	1331	A
O	1331	1332	$
O	1332	1335	105
O	1336	1339	231
O	1340	1343	and
O	1344	1345	A
O	1345	1346	$
O	1346	1348	90
O	1349	1352	842
O	1352	1353	,
O	1354	1366	respectively
O	1366	1367	.

O	1368	1375	However
O	1375	1376	,
O	1377	1388	sensitivity
O	1389	1397	analyses
O	1398	1406	indicate
O	1407	1411	that
O	1412	1423	incremental
O	1424	1428	cost
O	1429	1432	per
O	1433	1437	QALY
O	1438	1444	gained
O	1445	1448	was
O	1449	1457	volatile
O	1458	1460	to
O	1461	1468	EuroQol
O	1468	1469	-
O	1469	1471	5D
O	1471	1472	-
O	1472	1474	3L
O	1475	1482	weights
O	1482	1483	.

O	1484	1492	Findings
O	1493	1500	suggest
O	1501	1505	that
O	1506	1507	a
O	1508	1517	pragmatic
O	1518	1526	exercise
O	1527	1539	intervention
O	1540	1546	yields
O	1547	1551	more
O	1552	1557	women
O	1558	1562	with
O	1563	1571	markedly
O	1572	1580	improved
B-outcome	1581	1588	quality
I-outcome	1589	1591	of
I-outcome	1592	1596	life
I-outcome	1597	1602	after
O	1603	1609	breast
O	1610	1616	cancer
O	1617	1621	than
O	1622	1627	usual
O	1628	1632	care
O	1633	1636	and
O	1637	1640	may
O	1641	1643	be
O	1644	1648	cost
O	1648	1649	-
O	1649	1658	effective
O	1658	1659	.

O	1660	1663	The
O	1664	1671	results
O	1672	1675	are
O	1676	1680	less
O	1681	1688	certain
O	1689	1691	in
O	1692	1697	terms
O	1698	1700	of
O	1701	1712	incremental
O	1713	1717	cost
O	1718	1721	per
O	1722	1729	quality
O	1729	1730	-
O	1730	1738	adjusted
O	1739	1743	life
O	1744	1749	years
O	1749	1750	;
O	1751	1758	however
O	1758	1759	,
O	1760	1764	this
O	1765	1768	may
O	1769	1771	be
O	1772	1774	an
O	1775	1788	inappropriate
O	1789	1796	measure
O	1797	1800	for
O	1801	1811	reflecting
O	1812	1820	exercise
O	1821	1828	benefit
O	1829	1832	for
O	1833	1838	women
O	1839	1843	with
O	1844	1850	breast
O	1851	1857	cancer
O	1857	1858	.
